Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Synflorix and Infanrix-IPV/Hib in Preterm Children
NCT00609492Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2008
- Primary completion
- Nov 2008
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Jan 2008; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00609492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609492.